72 results on '"Björkholm, M"'
Search Results
2. Incidence of myeloproliferative neoplasms – trends by subgroup and age in a population‐based study in Sweden
3. YOUNG HIGH RISK PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA INCLUDING BCL-2/MYC DOUBLE HIT LYMPHOMAS BENEFIT FROM DOSE-DENSE IMMUNOCHEMOTHERAPY WITH EARLY CNS PROPHYLAXIS
4. DOSE-DENSE CHEMOIMMUNOTHERAPY AND CNS PROPHYLAXIS IN PATIENTS WITH HIGH-RISK DLBCL: A COMPARISON OF NORDIC CRY-04 AND CHIC STUDIES
5. Intravenous immunoglobulin treatment in cytopenic haematological disorders
6. Brain tumors in patients with myotonic dystrophy: a population‐based study
7. Aplastic anaemia: pathogenetic mechanisms and treatment with special reference to immunomodulation
8. Dendritic Cells in Bone Marrow at Diagnosis and after Chemotherapy in Adult Patients with Acute Myeloid Leukaemia
9. Fludarabine and plasma cell leukemia
10. Natural killer cell activity in monoclonal gammopathies: Relation to disease activity
11. Etoposide, doxorubicin, cyclophosphamide and high-dose betamethasone (EACB) as outpatient salvage therapy for refractory multiple myeloma
12. Alternating combination chemotherapy (VMCP/VBAP) is not superior to melphalan/prednisone in the treatment of multiple myeloma patients stage III -A randomized study from MGCS
13. Type-specific anti-pneumococcal antibody subclass response to vaccination after splenectomy with special reference to lymphoma patients
14. Spontaneously DNA Synthesizing Blood and Spleen Lymphocytes in Hodgkin's Disease
15. T Cells in Monoclonal Gammopathies
16. Blood and Lymph Node T-Lymphocyte Subsets in Non-Hodgkin Lymphomas
17. Membrane Bound IgG on Erythroblasts in Pure Red Cell Aplasia following Thymectomy
18. Immunological Family Studies in Hodgkin's Disease
19. Routine Laboratory Tests in Relation to Spleen Size and Tumour Involvement in Untreated Hodgkin's Disease
20. Immunological Defects in Healthy Twin Siblings to Patients with Hodgkin's Disease
21. No Evidence of a Lymphocytopenia State before Manifestation of Chronic Lymphocytic Leukemia
22. Prognostic Influence of Early Diagnostic Splenectomy in Hodgkin's Disease
23. A longitudinal study of class and subclass antibody response to pneumococcal vaccination in splenectomized individuals with special reference to patients with Hodgkin's disease
24. Intermittent Melphalan and Prednisolone Therapy in Plasma Cell Myeloma
25. No Effect of Delayed Cutaneous Hypersensitivity Testing (Multitest) on Blood Lymphocyte Counts and Functions
26. Clinical Findings and Prognostic Factors in Chronic Myeloid Leukemias
27. Immunologic Profile of Patients with Cured Hodgkin's Disease
28. On the Size and Tumor Involvement of the Spleen in Hodgkin's Disease
29. Increased luminol-enhanced chemiluminescence of blood monocytes and granulocytes in Hodgkin's disease
30. Quality of life before and one year following stem cell transplantation using an individualized and a standardized instrument
31. Granulocyte‐macrophage colony‐stimulating factor to increase efficacy of mitoxantrone, etoposide and cytarabine in previously untreated elderly patients with acute myeloid leukaemia: a Swedish multicentre randomized trial
32. Leucocyte doubling time is a useful predictor of progression-free survival in chronic lymphocytic leukaemia
33. Reactivation of chronic hepatitis C after withdrawal of immunosuppressive therapy
34. Disseminated Mycobacterium malmoense infection in a patient with chronic granulocytic leukaemia
35. Monitoring of hearing during treatment of leukaemia with special reference to the use of amikacin
36. Haematologic effects of granulocyte-macrophage colony stimulating factor in a patient with thiamazole-induced agranulocytosis
37. Hyperleukocytic effects on skin capillary circulation in patients with leukaemia
38. Treatment of multiple myeloma with interferon alpha: the Scandinavian experience
39. Successful treatment of hepatosplenic candidiasis with a liposomal amphotericin B preparation
40. Surface immunoglobulin pattern of the leukaemic cell population in chronic lymphocytic leukaemia (CLL) in relation to disease activity
41. Lymphocyte abnormalities in untreated patients with Hodgkin's disease
42. Epstein‐Barr virus‐associated antibody pattern in untreated non‐Hodgkin lymphoma patients. Relationship to clinical variables and lymphocyte functions
43. Immunodeficiency and Prognosis in Hodgkin's Disease
44. Tumour imaging of indium‐111 oxine‐labelled autologous lymphocytes as a staging method in Hodgkin's disease
45. Prognostic factors in hodgkin's disease with special reference to age
46. Therapeutic effects of low‐dose cytosine arabinoside, alpha‐interferon, 1α‐hydroxyvitamin D3 and retinoic acid in acute leukemia and myelodysplastic syndromes
47. Prognostic Factors in Hodgkin's Disease
48. AMPLIFICATION OF THE C‐MYC ONCOGENE IN HUMAN PLASMA‐CELL LEUKEMIA
49. T lymphocyte subpopulations in chronic lymphocytic leukemia of B cell type in relation to immunoglobulin isotype(s) on the leukemic clone and to clinical features
50. High doses of natural α‐interferon (α‐IFN) in the treatment of multiple myeloma — A pilot study from the Myeloma Group of Central Sweden (MGCS)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.